The potential of NSAIDs in the treatment of oesophageal carcinoma.
Morgan
G
G
West Glamorgan Health Authority, UK.
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D004938:Esophageal Neoplasms / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000970:Antineoplastic Agents